Internal Medicine, Infectious Disease · Laredo, TX
NPI
1598863813
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
121 Calle del Norte Ste 104
Laredo, TX, 78041
Phone (956) 722-0995
Groups this clinician bills Medicare through
Medicare paid, 2024
$126K
2,089 services
Medicare patients, 2024
437
Average age 73
Drug cost, 2024
$1.8M
1,349 prescriptions
Company payments, 2025
$262
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Fernando L Sanchez was code 99232 (hospital e&m - subsequent), 1,332 times for 267 patients. In total Fernando L Sanchez billed 2,089 services in 16 codes, and Medicare paid $126K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-08-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 1,332 | 267 | $59.62 | $79K |
| 99221 Hospital E&M - Initial | Facility | 360 | 279 | $62.65 | $23K |
| 99213 Office E&M - Established | Office | 293 | 136 | $60.60 | $18K |
| 99203 Office E&M - New | Office | 37 | 37 | $84.25 | $3,117 |
| 90658 Vaccine Product | Office | 17 | 17 | $21.42 | $364 |
| G0008 Administration of influenza virus vaccine | Office | 17 | 17 | $28.38 | $482 |
By year: 2022 $76K for 1,294 services; 2023 $132K for 2,142 services; 2024 $126K for 2,089 services.
Medicare prescription drug claims, 2024
In 2024, the drug Fernando L Sanchez prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 189 prescriptions and refills. In total Fernando L Sanchez wrote 1,349 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 189 | 189 | 18 | $723K |
| Doxycycline Hyclate Generic | 79 | 140 | 49 | $2,360 |
| Cephalexin Generic | 57 | 110 | 29 | $857 |
| Fluconazole Generic | 57 | 82 | 27 | $3,853 |
| Daptomycin Generic | 53 | 53 | 15 | $35K |
| Atorvastatin Calcium Generic | 38 | 91 | Under 11 | $132 |
| Cefdinir Generic | 32 | 42 | 27 | $1,270 |
| Ceftriaxone Ceftriaxone Sodium | 27 | 27 | Under 11 | $865 |
| Lisinopril Generic | 27 | 57 | Under 11 | $73.11 |
| Clindamycin Hcl Generic | 24 | 56 | Under 11 | $581 |
| Ertapenem Ertapenem Sodium | 23 | 23 | 14 | $8,333 |
| Epclusa Sofosbuvir/Velpatasvir | 22 | 22 | Under 11 | $523K |
| Dovato Dolutegravir Sodium/Lamivudine | 22 | 22 | Under 11 | $71K |
| Amlodipine Besylate Generic | 22 | 44 | Under 11 | $37.48 |
| Metformin Hcl Generic | 22 | 60 | Under 11 | $89.34 |
Brand drugs: - claims; generic drugs: 944 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Fernando L Sanchez $262 ($262 in general payments such as food, travel and fees) from 5 companies. The largest payer was ViiV Healthcare Company with $155.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.